Live February 6-13, 2022

Edwards Lifesciences

New England

What is Aortic Stenosis?
Edwards Lifesciences

What is Transcatheter Aortic Valve Replacement?

Aortic stenosis is a build-up of calcium deposits on the valve, which causes it to narrow and reduce blood flow to the rest of your body. TAVR is a valve replacement surgery that is less invasive.

Edwards Lifesciences’ roots date to 1958, when Miles “Lowell” Edwards set out to build the first artificial heart.

Edwards was a 60-year-old, recently retired engineer holding 63 patents in an array of industries, with an entrepreneurial spirit and a dream of helping patients with heart disease. His fascination with healing the heart was sparked in his teens, when he suffered two bouts of rheumatic fever, which can scar heart valves and eventually cause the heart to fail.

We partner with physicians to innovate products designed to help patients live longer, healthier and more productive lives. We focus on medical technologies that address large and growing patient populations in which there are significant unmet clinical needs.

TAVR Patient Experience
Heart Health and Severe Aortic Stenosis: early diagnosis leads to better outcomes

Monday, February 7, 2022 7-8 p.m.

Wednesday, February 9, 2022 9-10 a.m.

Friday, February 22, 2022 9-10 a.m.

Saturday, February 11, 2022 9-10 a.m.

Connect with Us

  • This field is for validation purposes and should be left unchanged.